SEC Contract Filing

Filing Date: 2024-08-21

Document Content:
<DOCUMENT>
<TYPE>EX-10.1(2)
<SEQUENCE>6
<FILENAME>ea021197601ex10-1ii_silexion.htm
<DESCRIPTION>CONVERTIBLE PROMISSORY NOTE, DATED AUGUST 15, 2024, IN AN AMOUNT OF $1,250,000, ISSUED BY SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) TO EARLYBIRDCAPITAL, INC
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0 0pt; text-align: right"><B>Exhibit 10.1.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>THIS NOTE, AND THE SECURITIES ISSUABLE UPON CONVERSION
OF THIS NOTE, HAVE NOT, AS OF THE DATE HEREOF, BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR
THE APPLICABLE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER
THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION UNDER SUCH LAWS OR AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENT.
INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE
ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, TO THE EFFECT THAT SUCH
PLEDGE, SALE, ASSIGNMENT OR TRANSFER IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><U>CONVERTIBLE PROMISSORY NOTE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
 <TR STYLE="vertical-align: top">
 <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">$1,250,000</FONT></TD>
 <TD STYLE="text-align: right; width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">August 15, 2024</FONT></TD></TR>
 </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Biomotion Sciences
and its successors and assigns (the &ldquo;Maker&rdquo;) promises to pay to the order of EarlyBirdCapital, Inc. (the &ldquo;Payee&rdquo;)
the principal sum of one million two hundred fifty thousand and zero one-hundredths ($1,250,000) in lawful money of the United States
of America, together with interest on the unpaid principal balance of this Note, on the terms and conditions described below, unless earlier
converted pursuant to the terms and conditions set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">1.&nbsp;<U>Payment</U>.
The principal balance of this Note, together with all interest accrued thereon, shall be repayable on December 31, 2025 (the &ldquo;Maturity
Date&rdquo;); provided however that Maker agrees to make mandatory prepayments on this Note (which shall first be applied to accrued interest
and then to principal) from time to time in amounts equal to ten percent (10%) of the gross proceeds received by the Maker from any equity
lines, forward purchase agreements or other equity financings consummated by Maker prior to the Maturity Date. Such prepayments shall
be made directly to Payee at the closing of any such financing. Provided, further, that, Maker shall be entitled to prepay any additional
part of all the principal and accrued interest, in one or more installments without penalty, prior to the Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">2.&nbsp;<U>Interest</U>.
Interest shall compound and accrue on the unpaid principal balance of this Note at an annual rate equal to six percent (6%) to, but excluding,
the date on which the principal amount of, and all accrued interest on, this Note has been paid in full. If this Note is not repaid on
or prior to the Maturity Date or such earlier date as to which the repayment obligation may be accelerated pursuant to Section 1 or 6,
or converted in accordance with the terms hereof, the rate of interest applicable to the unpaid principal amount shall be adjusted to
ten percent (15%) per annum from, and including, the Maturity Date (or such earlier date if the obligation to repay this Note is&nbsp;accelerated)
to, but excluding, until the date of repayment; provided, that in no event shall the interest rate exceed the Maximum Rate (defined below).
If it is determined that, under the laws relating to usury applicable to Maker or the indebtedness evidenced by this Note (&ldquo;Applicable
Usury Laws&rdquo;), the interest charges and fees payable by Maker in connection herewith or in connection with any other document or
instrument executed and delivered in connection herewith cause the effective interest rate applicable to the indebtedness evidenced by
this Note to exceed the maximum rate allowed by law (the &ldquo;Maximum Rate&rdquo;), then such interest rate shall be lowered to the
Maximum Rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
 <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
 <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
 <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; mar